scholarly journals Migrating Polyarthritis as a Feature of Occult Malignancy: 2 Case Reports and a Review of the Literature

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Geoffrey Alan Watson ◽  
Lorraine O’Neill ◽  
Ruth Law ◽  
Geraldine McCarthy ◽  
Douglas Veale

Malignant disease may be associated with a wide variety of musculoskeletal syndromes. Rarely the musculoskeletal system can be indirectly affected by paraneoplastic phenomena, such as carcinomatous polyarthritis (CP). The differential diagnosis for CP is broad and is often a diagnosis of exclusion. CP often presents similarly to other forms of inflammatory arthritis, and a detailed history and physical examination can often distinguish CP from other more common causes of polyarticular arthritis. However serological tests such as rheumatoid factor (RF) and anti-citrullinated peptide (anti-CCP) antibody positivity, while rare, can be misleading. Clinical awareness and suspicion are paramount in achieving an accurate diagnosis and early detection of an occult neoplasm is critical for prompt management and therapy. We report two cases presenting with this unique clinical phenotype associated with paraneoplastic polyarthropathy and review the literature.

2019 ◽  
Vol 19 (2) ◽  
pp. e271-e275 ◽  
Author(s):  
Sara Tanini ◽  
Alessandra D. Fisher ◽  
Icro Meattini ◽  
Simonetta Bianchi ◽  
Jiska Ristori ◽  
...  

Author(s):  
Márcia Marinho ◽  
Sara Nunes ◽  
Cátia Lourenço ◽  
Mónica Melo ◽  
Cristina Godinho ◽  
...  

Author(s):  
Mateusz Kozłowski ◽  
Katarzyna Nowak ◽  
Agnieszka Kordek ◽  
Aneta Cymbaluk-Płoska

Carcinosarcoma, leiomyosarcoma, melanoma and carcinoid as primary tumors in the ovary are extremely rare. In this paper, the authors reviewed the literature from 2010 to 2021, based on specific criteria, to analyze the treatment of these rare ovarian neoplasms. We also aimed to verify whether modern therapies have been found in recent years. For this article, 80 papers were finally selected. The vast majority of the articles were clinical case reports. Despite single mentions of new potential pharmacological treatments, surgery (radical or fertility-sparing) is definitely the mainstay of treatment. There are currently no treatment guidelines for these tumors. A review of the literature has revealed the use of various adjuvant treatments. We, therefore, believe that a more detailed understanding of the biology of these tumors is necessary in order to find new target points for treatment. We would like to emphasize the importance of creating an international database of rare ovarian tumors which would make it possible to gather data from various oncological centers and enable further research into these neoplasms.


2021 ◽  
Vol 81 ◽  
pp. 105720
Author(s):  
Youssef Oukessou ◽  
Yassir Hammouda ◽  
Khadija El Bouhmadi ◽  
Redallah Larbi Abada ◽  
Mohamed Roubal ◽  
...  

1994 ◽  
Vol 152 (5 Part 1) ◽  
pp. 1568-1571 ◽  
Author(s):  
Joseph G. Borer ◽  
Kenneth I. Glassberg ◽  
E. George Kassner ◽  
David A. Schulsinger ◽  
Unni M.M. Mooppan

1995 ◽  
Vol 70 (6) ◽  
pp. 570-572 ◽  
Author(s):  
Vincent Baty ◽  
Bruno Hoen ◽  
Hervé Hudziak ◽  
Catherine Aghassian ◽  
Claude Jeandel ◽  
...  

2000 ◽  
Vol 118 (4) ◽  
pp. A1150-A1151
Author(s):  
Wolfgang Mohl ◽  
Markus Menges ◽  
Cornelius Moser ◽  
Gemot Feifel ◽  
Bernhard Kramann ◽  
...  

2004 ◽  
Vol 25 (6) ◽  
pp. 465-468 ◽  
Author(s):  
Ercan Cetinus ◽  
Ilhan Cever ◽  
Cemal Kural ◽  
Haldun Erturk ◽  
Mustafa Akyildiz

Sign in / Sign up

Export Citation Format

Share Document